Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,080 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition.
Gravemeyer J, Lange A, Ritter C, Spassova I, Song L, Picard D, Remke M, Horny K, Sriram A, Gambichler T, Schadendorf D, Hoffmann D, Becker JC. Gravemeyer J, et al. Among authors: schadendorf d. J Invest Dermatol. 2021 Jul;141(7):1675-1686.e4. doi: 10.1016/j.jid.2021.01.012. Epub 2021 Feb 16. J Invest Dermatol. 2021. PMID: 33600825 Free article.
Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG).
Zimpfer-Rechner C, Hofmann U, Figl R, Becker JC, Trefzer U, Keller I, Hauschild A, Schadendorf D. Zimpfer-Rechner C, et al. Among authors: schadendorf d. Melanoma Res. 2003 Oct;13(5):531-6. doi: 10.1097/00008390-200310000-00012. Melanoma Res. 2003. PMID: 14512795 Clinical Trial.
Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
Paschen A, Sucker A, Hill B, Moll I, Zapatka M, Nguyen XD, Sim GC, Gutmann I, Hassel J, Becker JC, Steinle A, Schadendorf D, Ugurel S. Paschen A, et al. Among authors: schadendorf d. Clin Cancer Res. 2009 Aug 15;15(16):5208-15. doi: 10.1158/1078-0432.CCR-09-0886. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671853
Panel sequencing melanomas.
Griewank KG, Schadendorf D. Griewank KG, et al. Among authors: schadendorf d. J Invest Dermatol. 2015 Feb;135(2):335-336. doi: 10.1038/jid.2014.420. J Invest Dermatol. 2015. PMID: 25573045 Free article.
Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia.
Scholz SL, Thomasen H, Reis H, Möller I, Darawsha R, Müller B, Dekowski D, Sucker A, Schilling B, Schadendorf D, Steuhl KP, Paschen A, Westekemper H, Meller D, Griewank KG. Scholz SL, et al. Among authors: schadendorf d. Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5854-61. doi: 10.1167/iovs.15-17469. Invest Ophthalmol Vis Sci. 2015. PMID: 26348634
1,080 results